Schedule 13D ownership disclosure

Corvus Pharmaceuticals Inc

Security class unavailable · CUSIP: 221015100

Event date: 2018-03-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-016167
Form type
SC 13D
Filer
ADAMS STREET PARTNERS LLC
CIK
CIK 1193586
Filed
Mar 21, 2018
Reporting period
Mar 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub